The Boston Beer Company, Inc. (SAM) Stock Forecast
Data as of May 2, 2026Consumer Defensive · Current price $215.37 (-9.14%)
Price Target Range
Consensus Price Target Over Time
Analyst Rating Distribution
Last 3 Months
6-Month Trend
Latest Analyst Forecasts
Price targets issued by Wall Street analysts. Upside calculated against today's price.
| Date | Analyst | Firm | Price Target | Upside |
|---|---|---|---|---|
| Feb 20, 2026 | Nik Modi | RBC Capital | $245.00 | +13.8% |
| Jul 28, 2025 | Nadine Sarwat | Bernstein | $230.00 | +6.8% |
| Jul 26, 2024 | William Kirk | Roth Capital | $389.00 | +80.6% |
| Jul 26, 2024 | Nik Modi | RBC Capital | $318.00 | +47.7% |
| Jul 26, 2024 | Michael Lavery | Piper Sandler | $325.00 | +50.9% |
| Jul 12, 2024 | Michael Lavery | Piper Sandler | $344.00 | +59.7% |
| Jun 5, 2024 | Eric Serotta | Morgan Stanley | $290.00 | +34.7% |
| May 14, 2024 | Kaumil Gajrawala | Jefferies | $360.00 | +67.2% |
| Apr 29, 2024 | Steve Powers | Deutsche Bank | $273.00 | +26.8% |
| Apr 18, 2024 | Eric Serotta | Evercore ISI | $310.00 | +43.9% |
| Apr 15, 2024 | Steve Powers | Deutsche Bank | $264.00 | +22.6% |
| Mar 21, 2024 | Michael Lavery | Piper Sandler | $350.00 | +62.5% |
| Jan 16, 2024 | Nadine Sarwat | Bernstein | $335.00 | +55.5% |
| Jul 21, 2023 | Gerald Pascarelli | Wedbush | $325.00 | +50.9% |
| Jan 4, 2023 | Kevin Grundy | Jefferies | $275.00 | +27.7% |
| Oct 17, 2022 | Kaumil Gajrawala | Credit Suisse | $405.00 | +88.1% |
| Jul 7, 2022 | Nik Modi | RBC Capital | $331.00 | +53.7% |
| Apr 25, 2022 | Kaumil Gajrawala | Credit Suisse | $620.00 | +187.9% |
| Apr 24, 2022 | Wendy Nicholson | Citigroup | $375.00 | +74.1% |
| Dec 20, 2021 | Kevin Grundy | Jefferies | $535.00 | +148.4% |
Top Analysts Covering SAM
SAM vs Sector & Market
| Metric | SAM | Consumer Defensive Avg | Large Cap Avg |
|---|---|---|---|
| Analyst Rating | 3.00 | 2.55 | 2.41 |
| Analyst Count | 10 | 12 | 18 |
| Target Upside | +14.6% | +1188.8% | +14.9% |
| P/E Ratio | 22.11 | -7.38 | 31.19 |
Revenue Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2026-12-27 | $1.94B | $1.97B | $2.02B | 10 |
| 2027-03-27 | $442M | $450M | $469M | 3 |
| 2027-06-27 | $582M | $592M | $617M | 6 |
| 2027-09-27 | $554M | $564M | $588M | 5 |
| 2027-12-27 | $388M | $395M | $411M | 4 |
| 2028-03-27 | $445M | $452M | $471M | 3 |
| 2028-06-27 | $579M | $589M | $614M | 2 |
| 2028-09-27 | $558M | $567M | $591M | 2 |
| 2028-12-27 | $398M | $404M | $421M | 2 |
| 2029-12-27 | $2.00B | $2.05B | $2.10B | 7 |
| 2030-12-27 | $2.02B | $2.07B | $2.12B | 8 |
EPS Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2026-12-27 | $9.02 | $9.89 | $11.11 | 9 |
| 2027-03-27 | $2.15 | $2.20 | $2.32 | 2 |
| 2027-06-27 | $5.54 | $5.66 | $5.97 | 5 |
| 2027-09-27 | $4.66 | $4.76 | $5.02 | 4 |
| 2027-12-27 | $-1.57 | $-1.49 | $-1.46 | 3 |
| 2028-03-27 | $2.35 | $2.41 | $2.54 | 4 |
| 2028-06-27 | $5.66 | $5.79 | $6.11 | 3 |
| 2028-09-27 | $4.85 | $4.96 | $5.23 | 3 |
| 2028-12-27 | $-1.33 | $-1.26 | $-1.24 | 3 |
| 2029-12-27 | $13.75 | $14.18 | $14.63 | 2 |
| 2030-12-27 | $14.91 | $15.38 | $15.87 | 2 |
Frequently Asked Questions
What is the analyst consensus for SAM?
The consensus among 10 analysts covering The Boston Beer Company, Inc. (SAM) is Hold with an average price target of $233.00.
What is the highest price target for SAM?
The highest price target for SAM is $1340.00, set by Trevor Stirling at Bernstein on 2021-05-24.
What is the lowest price target for SAM?
The lowest price target for SAM is $230.00, set by Nadine Sarwat at Bernstein on 2025-07-28.
How many analysts cover SAM?
10 analysts have issued ratings for The Boston Beer Company, Inc. in the past 12 months.
Is SAM a buy or sell right now?
Based on 10 analyst ratings, SAM has a consensus rating of Hold (3.00/5) with a +14.6% upside to the consensus target of $233.00.
What are the earnings estimates for SAM?
Analysts estimate SAM will report EPS of $9.89 for the period ending 2026-12-27, with revenue estimated at $1.97B.
Related Stock Forecasts
Data updated daily. Analyst price targets sourced from public filings and broker reports. Not investment advice.